PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
Saved in:
| Title: | PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma. |
|---|---|
| Authors: | Barkdull S; a Dermatology Branch, Center for Cancer Research , National Cancer Institute, NIH , Bethesda , MD , USA., Brownell I; a Dermatology Branch, Center for Cancer Research , National Cancer Institute, NIH , Bethesda , MD , USA. |
| Source: | Cancer biology & therapy [Cancer Biol Ther] 2017 Dec 02; Vol. 18 (12), pp. 937-939. Date of Electronic Publication: 2017 Nov 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
